Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. CPRT
5. SPY
6. SEDG
7. ACVA
8. TLT
9. PMTS
10. TENB

Go back to Edesa Biotech Reports Enrollment Milestone in Phase 3 ARDS Study
(NASDAQ: EDSA) Delayed: 4.66 --0 (-0%)
Previous Close $4.66    52 Week High $ 
Open $4.66    52 Week Low $ 
Day High $4.66    P/E N/A 
Day Low $4.66    EPS $ 
Volume 281